TickerFactsScreenerDevelopers

Grace Therapeutics, Inc. (GRCE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2019: -$34.41M2020: -$24.44M2021: -$16.42M2022: -$15.59M2023: -$52.16M2024: -$12.85M2025: -$16.68M-$16.68M
2019Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$16.68M-29.8%
2024-$12.85M+75.4%
2023-$52.16M-234.6%
2022-$15.59M+5.1%
2021-$16.42M+32.8%
2020-$24.44M+29.0%
2019-$34.41M—